| 产品描述: | 一种基于不可逆机制的LSD1抑制剂的抗癌化合物;an anti cancer compound that is irreversible mechanism-based inhibitor of LSD1;抑制癌细胞系中细胞增殖的化合物。它是基于不可逆机制的LSD1抑制剂。LSD1是依赖家庭的胺氧化酶的一部分,其中包括PAO和MAO。;A compound that inhibits cell proliferation in cancer cell lines. It does this by being an irreversible mechanism-based inhibitor of LSD1. LSD1 is part of the family-dependant amine oxidases that include PAOs and MAOs. |
| 参考文献: |
1. Ramms B, et al. Systemic LSD1 Inhibition Prevents Aberrant Remodeling of Metabolism in Obesity. Diabetes. 2022 Dec 1;71(12):2513-2529. 2. Hong KS, et al. GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro. Signal Transduct Target Ther. 2020 Nov 17;5(1):267. 3. Alsaqer SF, et al. Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis. Oncotarget. 2017 Jul 27;8(43):73372-73386. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.457 ml |
17.287 ml |
34.573 ml |
| 5 mM |
0.691 ml |
3.457 ml |
6.915 ml |
| 10 mM |
0.346 ml |
1.729 ml |
3.457 ml |
| 50 mM |
0.069 ml |
0.346 ml |
0.691 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |